Skip to content

Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting

Phase II - Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult Male Circumcision Programs in Zimbabwe (Comparative Study)

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01956370
Enrollment
240
Registered
2013-10-08
Start date
2011-11-30
Completion date
2012-02-29
Last updated
2013-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

Male Circumcision, HIV Prevention, Medical Device

Brief summary

The protocol, approved by the Medical Research Council, was issued to assess the safety and efficacy of the non-surgical device for applying it to the national scale up of adult male circumcision in Zimbabwe

Detailed description

Models show that to have the highest impact on the HIV epidemic, circumcision of up to 80% of men in high prevalence countries, where MC rates are low, needs to be achieved (UNAIDS 2009; Manicaland HIV/STD Prevention Project, 2008; Bollinger, et al, 2009). Hallett and colleagues in 2008 showed that for Zimbabwe specifically, HIV incidence could be reduced between 25% to 35% if about 50% of men are circumcised. All modelings conducted show that MC programs must be part of a comprehensive HIV prevention package as MC alone will not tip the HIV epidemic into a terminal decline. The PrePex Device offers hope for rapid scale up of adult male circumcision in resource limited settings. Once the safety and efficacy have been established, it is important to conduct operations research to determine how best to implement both device and surgical circumcisions in the national program. Thus, the Zimbabwe MOHCW is planning a three phase trial in order to determine the safety of the PrePexTM device, its performance and the ease of use in an implementation roll out.

Interventions

The PrePex™ device is designed to enable bloodless male circumcision procedure with no anesthesia and no sutures.

The penis will be surgically circumcised according to one of the WHO recommended circumcision methods as described in the Manual for Male Circumcision under Local Anaesthesia Version 2.5C January 2008

Sponsors

Ministry of Health and Child Welfare, Zimbabwe
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18 - 30 years * Uncircumcised * Wants to be circumcised * Agrees to be circumcised by any of the study methods,PrePexTM or Surgical as appropriate * HIV sero-negative * Able to understand the study procedures and requirements * Agrees to abstain from sexual intercourse and to keep caution not to directly rub the cut area if masturbating, for 8 weeks post removal (9 weeks total) * Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 8 weeks post removal (9 weeks total) * Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study * Subject agrees to anonymous video and photographs of the procedure and follow up visits * Agrees to stay overnight at the Hospital in order to follow pain measurements in the first 16 hours

Exclusion criteria

* Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision * HIV sero-positive * Subject with the following diseases/conditions: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias * Known bleeding / coagulation abnormality * Uncontrolled diabetes * Subject that to the opinion of the investigator is not a good candidate * Subject does not agree to anonymous video and photographs of the procedure and follow up visits * Refusal to take HIV test.

Design outcomes

Primary

MeasureTime frameDescription
Procedure time9 weeksTo compare the total operative time of the PrePex Device circumcision procedure versus the total operative time of surgical circumcision procedure.

Secondary

MeasureTime frameDescription
Sexual partner's attitudes9 weeksSexual partner's attitudes using questionnaires and investigating the partner's behavior change as a result of her partner's circumcision.
Effect on daily activities9 weeksEffect on daily activities using questionnaires. Inquiring and finding out if the MC procedure caused any missing of working days.
Expectations of men regarding the procedure9 weeksExpectations of men regarding the procedure using questionnaires
Satisfaction rate of the procedure9 weeksSatisfaction with procedure using questionnaires and evaluations
Attitudes towards procedure9 weeksAttitudes towards procedure using questionnaires
Sexual behavior9 weeksSexual behavior using questionnaires. Inquiring of sexual behavior before and after the circumcision, etc.
Perception of norms9 weeksPerception of norms using questionnaires
Sexual relations, performance, satisfaction9 weeksSexual relations, performance, satisfaction using questionnaires
Costs9 weeksEvaluating the cost of PrePex circumcision procedure when taking into account the following parameters: i. PrePex Procedure time and the resulting cost of provider's time ii. Cost of staff time for follow-up visits iii. Cost of equipment and supplies needed for the circumcision procedure
Cost-effectiveness9 weeksCost-effectiveness
Sharing information with family and friends9 weeksSharing information with family and friends by evaluating weather subjects would recommend the procedure to others using questionnaires

Countries

Zimbabwe

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026